User contributions for 169.230.155.123

6 December 2015

• 00:4400:44, 6 December 2015 diff hist +185 User talk:Oluwa2Chainz →Valsartan/sacubitril
• 00:4200:42, 6 December 2015 diff hist +1,245 User talk:Oluwa2Chainz →Valsartan/sacubitril
• 00:3600:36, 6 December 2015 diff hist +1,109 Sacubitril/valsartan Undid revision 693930790 by OluwaCurtis (talk) unexplained revert, & editor has not responded to request to engage on Talk while editing other articles. Please engage.

5 December 2015

• 21:5221:52, 5 December 2015 diff hist +511 Talk:Sacubitril/valsartan →This reads like an advertisement, but it's for a very controversial drug.
• 21:4321:43, 5 December 2015 diff hist +403 Wikipedia talk:WikiProject Medicine →Request for outside input on Valsartan/sacubitril
• 16:5216:52, 5 December 2015 diff hist +182 Talk:Sacubitril/valsartan →This reads like an advertisement, but it's for a very controversial drug.
• 16:5016:50, 5 December 2015 diff hist +228 Wikipedia talk:WikiProject Medicine →Request for outside input on Valsartan/sacubitril: new section
• 16:4916:49, 5 December 2015 diff hist −108 Sacubitril/valsartan Undid revision 693886333 by Elvey (talk) Please engage on the Talk page, or lets take to the medicine project talk page.
• 16:4716:47, 5 December 2015 diff hist +363 Talk:Sacubitril/valsartan →This reads like an advertisement, but it's for a very controversial drug.
• 16:4416:44, 5 December 2015 diff hist +1,233 Talk:Sacubitril/valsartan Undid revision 693886783 by Elvey (talk) Please see WP:TALK and do not revert my additions to the talk page again unless you want to finish this convo at ANI. Thanks
• 16:3916:39, 5 December 2015 diff hist +1,359 Sacubitril/valsartan →Medical uses: expand
• 16:1916:19, 5 December 2015 diff hist 0 Sacubitril/valsartan →Medical uses: typo
• 16:1916:19, 5 December 2015 diff hist +3,010 Sacubitril/valsartan →Medical uses: expand

2 December 2015

• 02:5602:56, 2 December 2015 diff hist +153 Prescription drug prices in the United States →Drug retail price: other OECD comparisons
• 02:5202:52, 2 December 2015 diff hist −100 Prescription drug prices in the United States →Drug retail price: not really a true statement. See http://aspe.hhs.gov/report/medicare-part-b-reimbursement-prescription-drugs and http://www.hrsa.gov/opa/
• 02:4202:42, 2 December 2015 diff hist +458 Prescription drug prices in the United States →Drug retail price: fraction of NHE over time
• 02:3302:33, 2 December 2015 diff hist −346 Prescription drug prices in the United States →Drug retail price: remove primary research from financially interested source. Clearly US drug prices are higher than in other OECD countries, but they're not routinely 8x higher

1 December 2015

• 02:2802:28, 1 December 2015 diff hist −1,288 Nootropic →Nutraceuticals: remove claims based only on primary references per MEDRS
• 00:5000:50, 1 December 2015 diff hist −5 Nootropic →Nutraceuticals: closer to what sources say
• 00:4000:40, 1 December 2015 diff hist +1,014 Nootropic →Nutraceuticals: expand

23 November 2015

• 23:0423:04, 23 November 2015 diff hist −255 Troglitazone →Lawsuits: remove tort lawyer spam link

20 November 2015

• 16:0116:01, 20 November 2015 diff hist −6 Ezetimibe/simvastatin →Subsequent debate and enquiries: 2 years after the last subject COMPLETED the study. Two years after the last pt was enrolled would not be notable, as protocol required following pts for 2 years
• 15:5615:56, 20 November 2015 diff hist −46 Ezetimibe/simvastatin →ENHANCE trial data: actually it was published in the NEJM
• 00:3200:32, 20 November 2015 diff hist +1,700 Talk:Abiraterone acetate →Unreported early phase trial

19 November 2015

• 20:2720:27, 19 November 2015 diff hist −268 Lindane →News stories and opinion articles: this story has been debunked http://www.wsj.com/articles/SB10615643591098100
• 20:2220:22, 19 November 2015 diff hist −46 Lindane →See also: only reference to lindane in the linked article is an unsourced statement that it is toxic to bees. Tag: section blanking
• 20:1720:17, 19 November 2015 diff hist −2 Lindane →Pharmaceutical uses: Any doctor can prescribe any drug off-label for any use in the United States. Thus "should not be", not "cannot be"
• 20:1620:16, 19 November 2015 diff hist +651 Lindane →Pharmaceutical uses: Persistent Organic Pollutants Committee
• 20:0120:01, 19 November 2015 diff hist −783 Lindane →Endometriosis risk: remove health-related claim supported solely by primary source. Looked for and did not find a secondary source Tag: section blanking
• 20:0020:00, 19 November 2015 diff hist −312 Lindane →Cancer risk: combine IARC 2015 refs
• 19:5919:59, 19 November 2015 diff hist +261 Lindane →Cancer risk: update IARC opinion
• 19:4819:48, 19 November 2015 diff hist +44 Lindane →Human health effects: non-primary source needed
• 19:4719:47, 19 November 2015 diff hist −1,388 Lindane →Morton Grove lawsuit: Hard to see how this really adds anything other than "Morton Grove is Bad" POV. The comments that led to the suit are not mentioned, nor are the corrections discussed. Doesn't tell us anything about the drug itself. Tag: section blanking
• 19:4119:41, 19 November 2015 diff hist +44 Lindane →Pharmaceutical uses: non-primary source needed

18 November 2015

• 20:3420:34, 18 November 2015 diff hist −9 Flibanserin →Approval process and advocacy: typo
• 20:3320:33, 18 November 2015 diff hist +1,181 Flibanserin →Approval process and advocacy: expand. The chronology missed a second application by Sprout that was also rejected.
• 20:1420:14, 18 November 2015 diff hist +592 Flibanserin →Approval process and advocacy: A little more detail on what the Advisory Committee actually said from the meeting's official minutes.
• 15:4115:41, 18 November 2015 diff hist +270 Flibanserin →Advocacy groups: add opposition group
• 15:3615:36, 18 November 2015 diff hist +29 Flibanserin →Advocacy groups: add opposition group
• 15:3415:34, 18 November 2015 diff hist +4 Flibanserin →Advocacy groups: hyperlink
• 15:3415:34, 18 November 2015 diff hist +714 Flibanserin →Advocacy groups: JAMA editorial
• 15:2715:27, 18 November 2015 diff hist +2 Flibanserin →Advocacy groups: typo
• 15:2515:25, 18 November 2015 diff hist +46 Flibanserin →Advocacy groups: adjust language to better match source. Source does not use word "pressure", does not say Sprout created the group, describes as a "coalition of women's groups". Lets not editorialize.
• 15:1515:15, 18 November 2015 diff hist −117 Flibanserin →Approval process and advocacy: adjust language to better match the source

17 November 2015

• 23:1323:13, 17 November 2015 diff hist +505 Flibanserin →Even the Score: added refs
• 23:0623:06, 17 November 2015 diff hist +513 Flibanserin →Even the Score: Condemnation of the FDA
• 22:5022:50, 17 November 2015 diff hist +47 Flibanserin moved material about Valeant takeover out of the lead. Its wasn't discussed in the body and its not really that topical
• 22:4622:46, 17 November 2015 diff hist −483 Flibanserin →Approval process and advocacy: replace popular media descriptions of what FDA approved drug for with what is in the pkg insert. Stripped newspaper sources, linked to label
• 01:3701:37, 17 November 2015 diff hist −18 Wikipedia:Identifying reliable sources (medicine) Undid revision 690998612 by Nbauman (talk) this is the intro paragraph for the entire paragraph. If you read it again, it makes more sense the way it was

13 November 2015

• 00:0100:01, 13 November 2015 diff hist +2 User talk:Oshwah →Dupont